Physician profile
Ivan Grunberger
NPI 1528062247
$24,422.75
in general payments reported to CMS, 2019-2025
25 companies · $1,806 in 2025
The $1,806 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,525 · 2020: $659 · 2021: $789 · 2022: $3,851 · 2023: $6,712 · 2024: $7,081 · 2025: $1,806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,956 · Travel and Lodging: $3,505 · Food and Beverage: $3,102 · Honoraria: $935 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,956.42 |
| Travel and Lodging | $3,504.82 |
| Food and Beverage | $3,102.44 |
| Honoraria | $935.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gyrus Acmi, INC. | $4,945.64 | 2023 | Soltive |
| Procept Biorobotics Corporation | $4,706.02 | 2019-2024 | Aquabeam System, Aquabeam Robotic System |
| Edap Technomed INC | $3,243.67 | 2021-2025 | |
| Olympus America INC. | $3,150.00 | 2022 | |
| Ambu A/S | $3,012.32 | 2023-2024 | |
| Boston Scientific Corporation | $1,646.83 | 2019-2023 | Rezum Generator |
| Janssen Global Services, LLC | $1,166.30 | 2019 | |
| Olympus Winter & Ibe Gmbh | $900.00 | 2024 | Single Use Repositionable Clip |
| Astellas Pharma US INC | $460.58 | 2019-2025 | Xtandi |
| Richard Wolf Medical Instruments Corp. | $332.24 | 2019-2022 | |
| Ambu INC. | $228.12 | 2021-2022 | |
| Histosonics, INC. | $130.44 | 2025 | |
| Abbvie INC. | $123.07 | 2020-2023 | |
| Pfizer INC. | $87.47 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $72.60 | 2022-2023 | Prolaris |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $61.06 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $42.59 | 2024-2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $34.88 | 2020 | |
| Coloplast Corp | $30.30 | 2020 | |
| Allergan, INC. | $29.47 | 2022 | |
| Janssen Biotech, INC. | $19.15 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Grunberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.